跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
GLAVRINXA 1,5 MG/DOSIS SOLUCIÓN ORAL
Approved
STANDARD
GLAVRINXA 1,5 MG/DOSIS SOLUCIÓN ORAL
Newline Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 17, 2026
Approval ID
1b71aed9c1dbbffa
Company
Newline Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
1b71aed9c1dbbffa
Drug Cima Aemps Name
GLAVRINXA 1,5 MG/DOSIS SOLUCIÓN ORAL
Register Number
91561
Holder Company Name
Newline Pharma S.L.U.
Marketing Company Name
Laboratorios Gebro Pharma S.A.
Authorization Date
2026-08-17
Dosage Form
SOLUCIÓN ORAL
Dose
1,5 mg/dosis
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Newline Pharma S.L.U.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 17, 2026
Approval ID
1b71aed9c1dbbffa
Type
Standard
Back to CIMA-AEMPS Approvals
GLAVRINXA 1,5 MG/DOSIS SOLUCIÓN ORAL - CIMA-AEMPS Drug Approval Details